AMAG Pharmaceuticals, Inc. Announces Data Presentations At The American Society Of Nephrology (ASN) Renal Week MeetingMain Category: Urology / NephrologyArticle Date: 09 Oct 2009 AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA. Full abstracts can now be viewed on the ASN website at http://www.asn-online.org. The three accepted abstracts are as follows: - "Hemoglobin Response by Baseline Hemoglobin and Iron Indices Following IV Ferumoxytol Treatment in Nondialysis CKD Patients" (Bolton et al.) - Abstract # 1088: Poster presentation; 10 am-12 pm, Friday, October 30, 2009 - "Gastrointestinal Tolerability of IV Ferumoxytol and Oral Iron Therapy in Patients with Iron Deficiency Anemia and Chronic Kidney Disease" (Spinowitz et al.) - Abstract #1093: Poster presentation; 10 am-12 pm, Friday, October 30, 2009 - "MRI-Based Renal Imaging with Ferumoxytol: Perfusion-Enhanced MRI in a Rabbit Model" (Lewis et al.) - Abstract #2979: Poster presentation; 10 am-12 pm, Saturday, October 31, 2009 Source AMAG Pharmaceuticals, Inc. Original article posted on Medical News Today. Articles not to be reproduced without permission of Medical News Today Medical News Today publishes the latest health news and health videos for consumers and health professionals. It has a searchable archive of over 100,000 health news articles. < back to medical news
|
||||
|





